Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway
- PMID: 40699739
- PMCID: PMC12110173
- DOI: 10.3390/cimb47050340
Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway
Abstract
Sepsis-associated acute kidney injury (S-AKI) is a severe complication in critically ill patients, marked by inflammation, oxidative stress, and renal dysfunction. This study aimed to evaluate the renoprotective effects of Fasudil (Fas), a Rho-associated kinase inhibitor, in a rat model of S-AKI induced by cecal ligation and puncture (CLP). Thirty-six Wistar albino rats were divided into control, CLP with saline, and Fas (100 mg/kg/day intraperitoneally) groups. Biochemical, histopathological, and molecular analyses were conducted to assess kidney function, oxidative stress, and inflammation. Fas treatment significantly decreased plasma malondialdehyde and TNF-α levels, reducing oxidative stress and systemic inflammation. Kidney function markers, including BUN and creatinine, showed marked improvement. Furthermore, Fas suppressed the expression of STAT-3 and NLRP-3 in renal tissues, highlighting its role in modulating key inflammatory pathways. Histological evaluation revealed alleviated renal damage, with less tubular necrosis and interstitial inflammation in the Fas-treated group. In conclusion, Fas demonstrates significant anti-inflammatory, antioxidant, and nephroprotective effects in S-AKI, primarily by inhibiting STAT-3 and NLRP-3 signaling. These results support its potential as a therapeutic agent in sepsis-induced kidney injury and suggest the need for further clinical evaluation.
Keywords: Fasudil; NLRP-3 inflammasome; Rho kinase inhibitor; STAT-3 pathway; sepsis-associated acute kidney injury.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Gómez H., Ince C., De Backer D., Pickkers P., Payen D., Hotchkiss J., Kellum J.A. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41:3–11. doi: 10.1097/SHK.0000000000000052. - DOI - PMC - PubMed
-
- Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure—Definition, outcome measures, animal models, fluid therapy and information technology, needs: The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit. Care. 2004;8:R204–R212. doi: 10.1186/cc2872. - DOI - PMC - PubMed
-
- Okada A., Fukushima K., Fujita M., Nakanishi M., Hamori M., Nishimura A., Shibata N., Sugioka N. Alterations in cisplatin pharmacokinetics and its acute/sub-chronic kidney injury over multiple cycles of cisplatin treatment in rats. Biol. Pharm. Bull. 2017;40:1948–1955. doi: 10.1248/bpb.b17-00499. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
